Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 5599-5601, November 1, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Özbal, C. C.
Right arrow Articles by Tannenbaum, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Özbal, C. C.
Right arrow Articles by Tannenbaum, S. R.

Conservation of Histone Carcinogen Adducts during Replication: Implications for Long-Term Molecular Dosimetry1

Can C. Özbal2, Ivana Velic3, Carlton K. SooHoo4, Paul L. Skipper and Steven R. Tannenbaum5

Department of Chemistry, Division of Toxicology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 [C. C. Ö., I. V., P. L. S., S. R. T.]

The effect of cell replication on histone-carcinogen adducts was investigated by determining the specific adduct levels as a function of time following carcinogen treatment of human TK6 cells grown in culture. Core histones isolated from cells treated with aflatoxin B1 or r-7,t-8 dihydroxy-t-9,t-10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene exhibited a decrease over five generations in specific adduct level that did not exceed the decrease expected as a result of dilution with newly synthesized protein except during the early phase (<1 generation) of the experiment when loss of chemically unstable adducts might occur. Similar kinetics without the initial, more rapid phase was observed when cells were treated with N-nitroso-N-methylurea. Multigeneration stability of aflatoxin B1 and N-nitroso-N-methylurea adducts that formed on histone H1 was also observed; in these experiments it was not possible to determine if there was an initial phase in the kinetics. These experiments indicate that cell replication does not result in the repair or removal of adducted histones, establishing the feasibility of using histone-carcinogen adducts for molecular dosimetry purposes.

1 This work was supported by National Institute of Environmental Health Services Grants ES04675 and ES02109.

2 Supported by National Institute of Environmental Health Services Grant ES07020.

3 Supported by Knoll AG, Ludwigshafen, Germany.

4 Present address: Repligen Corp., 1 Kendall Square, Cambridge, MA 02139.

5 To whom requests for reprints should be addressed, at Department of Chemistry, Division of Toxicology, Massachusetts Institute of Technology, Room 56-311, Cambridge, MA 02139-4307.

Received 6/ 6/94. Accepted 8/29/94.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Jiang, X. Zhou, K. Taghizadeh, M. Dong, and P. C. Dedon
N-formylation of lysine in histone proteins as a secondary modification arising from oxidative DNA damage
PNAS, January 2, 2007; 104(1): 60 - 65.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.